1. Home
  2. SRDX vs BVS Comparison

SRDX vs BVS Comparison

Compare SRDX & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • BVS
  • Stock Information
  • Founded
  • SRDX 1979
  • BVS 2011
  • Country
  • SRDX United States
  • BVS United States
  • Employees
  • SRDX N/A
  • BVS N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • SRDX Health Care
  • BVS Health Care
  • Exchange
  • SRDX Nasdaq
  • BVS Nasdaq
  • Market Cap
  • SRDX 415.4M
  • BVS 496.7M
  • IPO Year
  • SRDX 1998
  • BVS 2021
  • Fundamental
  • Price
  • SRDX $30.91
  • BVS $6.97
  • Analyst Decision
  • SRDX Buy
  • BVS Strong Buy
  • Analyst Count
  • SRDX 2
  • BVS 5
  • Target Price
  • SRDX $43.00
  • BVS $14.40
  • AVG Volume (30 Days)
  • SRDX 92.6K
  • BVS 445.1K
  • Earning Date
  • SRDX 07-30-2025
  • BVS 08-05-2025
  • Dividend Yield
  • SRDX N/A
  • BVS N/A
  • EPS Growth
  • SRDX N/A
  • BVS N/A
  • EPS
  • SRDX N/A
  • BVS N/A
  • Revenue
  • SRDX $121,575,000.00
  • BVS $567,699,000.00
  • Revenue This Year
  • SRDX N/A
  • BVS N/A
  • Revenue Next Year
  • SRDX $3.70
  • BVS $6.11
  • P/E Ratio
  • SRDX N/A
  • BVS N/A
  • Revenue Growth
  • SRDX N/A
  • BVS 8.60
  • 52 Week Low
  • SRDX $26.00
  • BVS $6.02
  • 52 Week High
  • SRDX $42.25
  • BVS $14.38
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 65.27
  • BVS 52.38
  • Support Level
  • SRDX $29.51
  • BVS $6.81
  • Resistance Level
  • SRDX $31.06
  • BVS $7.44
  • Average True Range (ATR)
  • SRDX 0.91
  • BVS 0.33
  • MACD
  • SRDX 0.18
  • BVS 0.07
  • Stochastic Oscillator
  • SRDX 86.61
  • BVS 61.48

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Share on Social Networks: